Upcoming CRF Events
Click link to view all CRF Events on Facebook
What’s NEW?
CRF ANNOUNCES NEW RESEARCH AWARD TO STUDY THE EFFICACY OF NOVEL THERAPEUTICS
Dr. Yi Zhai receives the Oster Family Research Award "This important research will provide a best-in-class way to evaluate the impact of future scientific research into choroideremia.” — Neal Bench, CRF board president SPRINGFIELD, MASSACHUSETTS, [...]
CHOROIDEREMIA RESEARCH FOUNDATION STRENGTHENS LEADERSHIP
Four New Members Join the Board of Directors Springfield, MA., July 16, 2020 The Choroideremia Research Foundation (CRF) is pleased to announce the appointment of four new members to its board of directors. These members [...]
Kim Edwards Receives 1st Annual CRF Randy Wheelock Research Award
Choroideremia Research Foundation Awards $50,000 Grant in New Program Springfield, MA., May 26, 2020 The Choroideremia Research Foundation (CRF) is pleased to announce that Kim Edwards is the recipient of the 1st Annual CRF Randy [...]
Choroideremia Research Foundation Announces Funding Grant for CHM Research
Dr. David Williams at UCLA to begin mitochondrial defects study to help find a cure for Choroideremia Springfield, MA., March 06, 2020 The Choroideremia Research Foundation recently announced a grant award for $61,000 to David [...]
The Choroideremia Research Foundation Announces Funding Grants for CHM Research
The CRF awards three research grants totaling $219,000 to continue leading efforts to find a cure for Choroideremia Springfield, MA., November 25, 2019 The Choroideremia Research Foundation announced three grant awards for studies focused on [...]
The Choroideremia Research Foundation Announces First Annual Randy Wheelock Research Award
Researchers may submit proposals for projects related to finding a cure for CHM by November 15, 2019 Springfield, MA., October 7, 2019 The Choroideremia Research Foundation (CRF) is honored to announce the creation of the [...]
The Choroideremia Research Foundation Announces New Executive Director and Chief Medical Officer
The Choroideremia Research Foundation announced the appointment of Kathi Wagner to the position of Executive Director and Chris Moen, MD to the position of Chief Medical Officer. Kathi Wagner brings 25 years of fundraising and [...]
Choroideremia Research Foundation Holds 2019 International Choroideremia Symposium
On June 6-7, the Choroideremia Research Foundation (CRF) hosted its 2019 International Choroideremia Symposium in Philadelphia, Pennsylvania. With the support of the Center for Advanced Retinal and Ophthalmic Therapeutics at the University of Pennsylvania, CRF [...]
4DMT and ROCHE Expand Ophthalmology Partnership to Develop and Commercialize Multiple AAV Gene Therapy Products
4D Molecular Therapeutics (4DMT), a leader in Therapeutic Vector Evolution for adeno-associated virus (AAV) gene therapy vector discovery and product development, today announced the expansion of its 2016 research agreement with F. Hoffmann-La Roche Ltd [...]
Nightstar Announces First-Ever Phase 3 Choroideremia Gene Therapy Trial
Nightstar Therapeutics has announced the initiation of the company’s STAR Phase 3 registrational trial to study the safety and efficacy of NSR-REP1 in patients with choroideremia. In data from 32 patients treated with NSR-REP1 across four [...]
Nightstar Therapeutics raises $75 Million in IPO to fund Pivotal Phase 3 Gene Therapy Study
Nightstar Therapeutics held it’s Initial Public Offering on Thursday September 28th, raising $75 Million which will be used to advance the company’s gene therapy treatment for Choroideremia along with other Retinal Degenerative Diseases the company is working on. [...]